Remus Pharmaceuticals

Remus Pharmaceuticals

665.20
-5.70
(-0.85%)
hide
Key Fundamentals
Add Ratio
Market Cap
790.60 Cr
EPS
65.21
PE Ratio
20.40
Dividend Yield
0.11 %
Industry
Healthcare
52 Week High
2,770.00
52 Week Low
636.10
PB Ratio
3.06
Debt to Equity
0.09
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.10
#1 3,98,049.70
38.75
#1 54,729.00
9.71
#1 10,980
-19.84
61.71
6,621.50
1,75,222.50
76.19
9,712.00
18.67
2,191
26.74
72.60
1,577.60
1,26,768.90
23.67
28,409.50
7.12
5,291
9.88
60.63
3,584.30
1,19,599.80
60.49
11,539.40
6.99
1,911
19.91
53.74
1,255.90
1,03,508.80
#1 18.25
33,741.20
16.73
5,725
1.26
48.97
2,476.60
1,01,344.60
53.48
12,744.20
#1 20.90
2,007
-18.14
47.04
987.65
99,073.80
21.09
23,511.00
18.55
4,615
2.60
45.37
1,940.00
89,121.90
23.79
22,909.50
13.74
3,306
#1 51.64
46.82
5,581.50
66,047.70
28.61
13,458.30
3.70
2,216
21.39
63.11
1,101.00
64,254.10
19.04
32,345.60
9.43
3,484
-10.24
50.87
Growth Rate
Revenue Growth
189.76 %
Net Income Growth
58.02 %
Cash Flow Change
417.78 %
ROE
-1.88 %
ROCE
-1.75 %
EBITDA Margin (Avg.)
35.81 %

Yearly Financial Results

Annual Financials
2024
2025
TTM
Revenue
216
625
0
Expenses
184
575
0
EBITDA
32
51
0
Operating Profit %
14 %
7 %
0 %
Depreciation
1
2
0
Interest
1
2
0
Profit Before Tax
30
47
0
Tax
6
9
0
Net Profit
24
38
0
EPS in ₹
42.97
65.21
0.00

Balance Sheet

Balance Sheet
2024
2025
Total Assets
333
433
Fixed Assets
14
16
Current Assets
212
221
Capital Work in Progress
0
0
Investments
105
186
Other Assets
215
231
Total Liabilities
333
433
Current Liabilities
141
122
Non Current Liabilities
17
29
Total Equity
175
283
Reserve & Surplus
156
250
Share Capital
2
6

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
4
3
Investing Activities
-25
-11
Operating Activities
1
7
Financing Activities
28
6

Share Holding

% Holding
Mar 2023
May 2023
Sept 2023
Mar 2024
Jun 2024
Sept 2024
Mar 2025
Jul 2025
Promoter
92.82 %
68.37 %
69.61 %
70.60 %
70.66 %
70.84 %
70.85 %
70.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.92 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.44 %
16.69 %
21.15 %
20.54 %
20.90 %
20.49 %
19.18 %
18.90 %
Others
0.74 %
14.02 %
9.24 %
8.85 %
8.44 %
8.67 %
9.97 %
10.25 %
No of Share Holders
30
1,743
856
1,124
1,577
1,753
398
2,017

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 6 1.5
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.27 0.23

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 Sept 2023 DIVIDEND Dividend
₹ 2.00 /share
15 Sept 2023 0.00 4,172.50
28 Oct 2023 DIVIDEND Dividend
₹ 2.00 /share
27 Oct 2023 5,493.50 5,599.00
13 Mar 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
13 Mar 2024 6,925.75 5,440.90
02 May 2024 DIVIDEND Dividend
₹ 4.00 /share
02 May 2024 6,340.10 7,369.00
21 May 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
21 May 2024 6,340.10 7,948.30
06 Jun 2024 BONUS Bonus
3:1
06 Jun 2024 7,200.25 7,227.95
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 2,621.65 2,410.90
09 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Nov 2024 2,542.60 2,536.65
20 Nov 2024 DIVIDEND Dividend
₹ 1.00 /share
19 Nov 2024 2,536.65 2,356.45
17 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 May 2025 1,832.50 2,207.70
04 Jul 2025 BONUS Bonus
1:1
04 Jul 2025 1,999.75 1,937.25
18 Sept 2025 DIVIDEND Dividend
₹ 0.50 /share
18 Sept 2025 2,207.70 811.25

Technical Indicators

RSI(14)
Neutral
22.83
ATR(14)
Less Volatile
29.93
STOCH(9,6)
Neutral
37.65
STOCH RSI(14)
Neutral
69.22
MACD(12,26)
Bearish
-0.20
ADX(14)
Very Strong Trend
59.19
UO(9)
Bearish
63.61
ROC(12)
Downtrend And Accelerating
-7.54
WillR(14)
Neutral
-77.42